Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease - Wikidata - awgldk - TriplyDB

Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease

Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease

http://www.wikidata.org/entity/Q34520661

about

Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases Cerebral small vessel disease and Alzheimer's disease Aβ Clearance, "hub" of Multiple Deficiencies Leading to Alzheimer Disease Hypertension: a harbinger of stroke and dementia The Glymphatic System: A Beginner's Guide Alzheimer's disease and non-demented high pathology control nonagenarians: comparing and contrasting the biochemistry of cognitively successful aging Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy.Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical update Cerebral microbleeds: overview and implications in cognitive impairment.Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?Soluble amyloid beta levels are elevated in the white matter of Alzheimer's patients, independent of cortical plaque severity.White matter is altered with parental family history of Alzheimer's disease Posterior white matter disease distribution as a predictor of amyloid angiopathy.Disproportionate subarachnoid space hydrocephalus-outcome and perivascular space Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease A disease modification effect of APOE E4 on the association between urinary albumin excretion and cognition in Korean adults.Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.Vascular risk factors and longitudinal changes on brain MRI: the ARIC study Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia.Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis Review of 'the potential role of arterial stiffness in the pathogenesis of Alzheimer's disease'.Virchow-Robin Spaces: Correlations with Polysomnography-Derived Sleep Parameters.Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment Three-dimensional observation of Virchow-Robin spaces in the basal ganglia and white matter and their relevance to idiopathic normal pressure hydrocephalus.Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.The feasibility of quantitative MRI of perivascular spaces at 7T.Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007 The role of APOE in cerebrovascular dysfunction Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships.Topography of dilated perivascular spaces in subjects from a memory clinic cohort.Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.

P2860

Q24596820-DC017A43-D528-44F3-BD41-E25175A03D21 Q26753215-92B266B3-7A72-4127-91FB-87D867138253 Q26775897-D9A52E6D-7B4D-4B7F-B0B2-14CFDEC28B37 Q26779681-F14366EC-A6F2-4348-BCC5-38925D4DC752 Q27027494-E9187DFA-66FD-4133-A884-874FE63D9195 Q28084591-06CA1047-BA51-44DE-8E30-B7A0F1B1E988 Q28477836-027CB21A-FE06-4F2C-BB53-2F3965EFA11D Q33654643-278B0CFB-EB6D-434C-BC44-0387E8B4A1F9 Q33700069-EA7D056C-C4C3-499D-9E62-DBE4F63A0522 Q33821536-D5DCF33C-9BC1-44C0-B9F4-58D4B4100A38 Q33828173-DF103A30-7CD4-429D-AB22-80060067CF83 Q34100175-35E3956B-A16C-4859-ADFB-67F0A2A5649A Q34103755-9244AD95-98F6-45B3-9C00-D5C465DE0ACC Q34135711-1A4BCAEF-DCF0-41C4-B78A-6657C45F7A1D Q34286406-DABB1CFF-5198-4059-ADE4-3846557508D1 Q34358146-C37F6C9A-A241-4BF8-9745-A79A70C38F36 Q34501344-23406E0E-1F35-4EE6-AC58-D637A8463316 Q35031724-527495C8-F088-47F3-8E10-E5BC8BF5E389 Q35047530-0A10CADC-AFC5-4949-B394-05326E5B26E4 Q35050945-85981A2B-1958-4458-BF83-F36B8F744AC4 Q35222076-764C4E8E-B7B6-4F7E-83B3-7C96ADE8E1F1 Q35581060-6F8BFEEA-51C5-44FD-93BA-4B9CCEDA9D7A Q35615444-0E8BE0F4-F973-4C93-B3A6-384D4784C746 Q35698618-C4184940-27E5-4A70-BE0E-A5369843D0DD Q35750582-571A680F-6F98-42B9-9855-E17842C1B2B1 Q35786540-F9AFBBF3-46A8-4C44-A29D-A5E56995E250 Q36019763-3D318CE3-7A8C-43AA-8D47-901362A5C9F4 Q36121377-DFFEA54A-6AFC-4C02-9CC8-7F80A77C7F77 Q36270381-658A8E6B-34A0-4F5D-B2D7-FBDC7CA3B222 Q36296823-269A161D-9C2A-4FFB-99EC-28BAFBB185FF Q36597843-1505A6D6-2D43-4776-9B2E-0F7E7625261A Q36692515-C809D75B-5C3E-44E9-BF80-CAD3B7031A09 Q36772901-A1AD10D0-F35D-45DA-AA79-467465853519 Q36805238-170F9E9E-9CB5-4502-9E1D-D0B34B4C3BE4 Q36813704-D2B0DA1A-39E7-4FAB-B041-CD5FD9E03040 Q36857484-895B9022-D9FD-411C-A561-94DBA365C5F4 Q36870150-C8009674-AC8B-4C0D-96A3-8FC56A7A94F9 Q37010838-B468D76A-D4E1-459B-86AC-1EE6725BACC1 Q37109969-C81AF7FB-886E-4348-A65E-66D0CC280799 Q37145570-8A6D3A58-3799-4997-87EF-7E75D35480F9

P2860

Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease

http://www.wikidata.org/entity/Q34520661

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@ast

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@en

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@nl

type

label

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@ast

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@en

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@nl

prefLabel

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@ast

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@en

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@nl

P1433

Q34520661-EF09951C-5873-468A-9712-3E6C6018ADA2

P1476

Q34520661-266377EE-7BAE-4ACE-B553-930B180D1301

P2093

Q34520661-2EB414D6-A1A0-4DE3-9DB7-6ACB6DB9B4D6

Q34520661-3DA628BA-D684-4776-B3E6-61801994A1E9

Q34520661-45231287-961F-4E96-8255-F40CCF01833F

Q34520661-691FA603-EA6C-467E-BB87-FA4CB96A0C52

Q34520661-82A961BF-C368-4494-9E9F-DAED1B0E2C49

Q34520661-88FEAB06-411C-457B-A50A-741DEC9E4D39

Q34520661-9E0F1A86-6413-469D-8860-8227850FFECD

Q34520661-9E5D5060-95EF-4591-8BC5-0DB10001B56F

Q34520661-B4F354BF-D881-43A6-A32E-81D9B1C329F6

Q34520661-BCB74D46-7DBE-47EA-9F4D-3A4E71949A17

P2860

Q34520661-032B8770-A94A-4B1E-9519-019ED0C0D316

Q34520661-0CA436C8-03A4-491F-857C-66178EA93467

Q34520661-0FBDFE63-0744-4752-B2D5-BB78A40F6B5F

Q34520661-1BF20B85-5280-45A0-AC55-FAC4F92C0C31

Q34520661-21B1C894-E5D0-4B8E-A4D3-FA0500FF90AF

Q34520661-3AD3E32E-FF47-478F-9988-12A84B8D34F3

Q34520661-623A607B-7AB7-4BB5-A1DB-0D549EDD0F6F

Q34520661-6508383C-039C-4C92-9A68-658B325616C6

Q34520661-72BD9064-946E-4107-BC89-50466D31C50C

Q34520661-8F8BB6F0-2EF4-47A7-B1F6-4B1EED5B2EAB

P304

Q34520661-6E6DBF45-D4DA-47DD-8A56-22FD7973DF02

P31

Q34520661-66C4544C-DB71-49BA-B434-18F48E4F7123

P407

Q34520661-CE5C7C5A-208D-4C44-98CC-BA9DF7615C73

P433

Q34520661-77CAFE3F-5E76-42EE-8F9B-653BD67AB406

P478

Q34520661-1DF7A38F-D511-45DB-A1F6-6D648E415F6B

P50

Q34520661-C642FBAF-C622-445F-B14D-324302CBC25D

P577

Q34520661-7F29A3B8-3EEE-4EE3-ADEC-025D23E22A70

P698

Q34520661-3FC3493D-DC4F-4194-803D-B4433E0FBF63

P921

Q34520661-6C8D4A41-58DA-441E-8DE4-BE79731D9106

Q34520661-bdda013a-d9cc-47a9-b3a6-40e1675063aa

P932

Q34520661-A94C179F-7B6D-4D35-A674-1CA278726C61

P1433

Molecular Medicine

P1476

Cortical and leptomeningeal ce ...... thology in Alzheimer's disease

@en

P2093

Alex E Roher

http://www.w3.org/2001/XMLSchema#string

Carmen Knebel

http://www.w3.org/2001/XMLSchema#string

Chera Esh

http://www.w3.org/2001/XMLSchema#string

Dean C Luehrs

http://www.w3.org/2001/XMLSchema#string

Jennifer L Childress

http://www.w3.org/2001/XMLSchema#string

Nicole Weiss

http://www.w3.org/2001/XMLSchema#string

Roy O Weller

http://www.w3.org/2001/XMLSchema#string

Tyler A Kokjohn

http://www.w3.org/2001/XMLSchema#string

Walter Kalback

http://www.w3.org/2001/XMLSchema#string

Yu-Min Kuo

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation

Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum

Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

Pathways of fluid drainage from the brain--morphological aspects and immunological significance in rat and man.

Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease.

P304

112-122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12865947

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1430731

http://www.w3.org/2001/XMLSchema#string